At what time is it appropriate to perform a Doppler (Doppler Ultrasound) study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Doppler Ultrasound in Pregnancy

For high-risk pregnancies with suspected fetal growth restriction (FGR), umbilical artery Doppler should be initiated at 26-28 weeks of gestation and performed every 2 weeks if normal, with increased frequency to weekly or 2-3 times per week when abnormalities are detected. 1, 2

Initial Screening in High-Risk Pregnancies

The optimal screening window for women at high risk of FGR is 19-24 weeks' gestation using maternal uterine artery Doppler, which can identify 90% of FGR cases delivering before 32 weeks. 2

  • Umbilical artery Doppler surveillance should begin at 26-28 weeks in high-risk pregnancies once the fetus is considered potentially viable 1, 2
  • Earlier assessment before 24 weeks should be avoided unless severe abnormalities are suspected, as accuracy and positive predictive values are unacceptable before this gestational age 2

Surveillance Frequency Based on Findings

Normal Umbilical Artery Doppler

  • Perform Doppler studies every 2 weeks when umbilical artery flow remains normal 1
  • Some protocols recommend testing at 2-4 week intervals when no abnormalities are detected 1

Abnormal Umbilical Artery Doppler with Forward Flow

  • Increase to weekly Doppler assessment when decreased end-diastolic velocity is detected (flow ratios >95th percentile) 1, 2
  • Weekly surveillance is also recommended for severe FGR with estimated fetal weight <3rd percentile 2

Absent End-Diastolic Velocity (AEDV)

  • Perform Doppler studies 2-3 times per week when AEDV is detected 1, 2
  • This finding may warrant hospitalization and consideration of antenatal corticosteroid administration 1

Reversed End-Diastolic Velocity (REDV)

  • REDV mandates hospitalization with cardiotocography at least 1-2 times daily and Doppler assessment 3 times weekly 2
  • This represents critical fetal compromise requiring intensive surveillance 2

Specific Clinical Scenarios

Monochorionic Twin Pregnancies

  • Begin routine umbilical artery and middle cerebral artery (MCA) Doppler surveillance at 16-20 weeks of gestation for twin-twin transfusion syndrome (TTTS) screening 1
  • In 84% of stage III or IV TTTS cases, abnormal Doppler findings were identified before TTTS diagnosis when surveillance included every-other-week Doppler evaluations 1
  • Once TTTS is diagnosed, umbilical artery and ductus venosus Doppler are necessary for staging and clinical management 1

Preeclampsia

  • Perform fetal biometry, amniotic fluid assessment, and Doppler studies immediately at diagnosis of preeclampsia, regardless of gestational age 2
  • Continue serial surveillance from 26 weeks' gestation when preeclampsia is confirmed and pregnancy continuation is planned 2

Uterine Artery Abnormalities

  • When uterine artery pulsatility index is above the 95th centile at 20 weeks, schedule growth ultrasounds and umbilical artery Doppler every 2 weeks 3
  • If FGR develops, increase umbilical artery Doppler frequency to weekly 3

Adjunctive Doppler Studies

Middle Cerebral Artery (MCA) Doppler

  • Consider MCA Doppler at 32 weeks or later in pregnancies with FGR 1
  • Perform every 2-3 weeks if umbilical artery Doppler is normal 1
  • MCA Doppler should not be relied upon for routine management as a primary screening modality; it is an adjunctive tool 2

Ductus Venosus Doppler

  • Ductus venosus studies are of unclear value as a component of routine monochorionic twin surveillance 1
  • However, ductus venosus Doppler is recommended following identification of atypical findings such as overt TTTS, isolated polyhydramnios, or coexisting FGR 1

Low-Risk Pregnancies

Routine Doppler ultrasound in low-risk or unselected populations is not recommended, as it does not confer benefit on mother or baby and does not result in improved perinatal outcomes. 1, 4

  • 83% of international guidelines concur that there is no role for universal Doppler screening in low-risk populations 2
  • Routine third-trimester ultrasound at 36 weeks for growth assessment is recommended by some guidelines, but Doppler is not part of routine low-risk surveillance 2

Critical Timing Considerations for Optimal Assessment

  • The optimal window for comprehensive assessment is 30-35 weeks if follow-up imaging is needed, as physiologic myometrial thinning after 35 weeks can limit accurate assessment 2
  • Avoid delaying Doppler assessment once FGR is suspected, as umbilical artery Doppler reduces perinatal death by 38% in high-risk pregnancies when incorporated into management 2

Common Pitfalls to Avoid

  • Do not perform detailed Doppler assessment before 24 weeks unless severe abnormalities are suspected, as accuracy is inadequate 2
  • Do not rely on MCA or ductus venosus Doppler as primary screening tools; umbilical artery Doppler is the primary modality 2
  • Do not use the same surveillance protocol for all high-risk conditions; tailor frequency based on specific Doppler findings 1, 2
  • When oligohydramnios accompanies IUGR with absent or reversed end-diastolic flow, surveillance up to 2-3 times per week is recommended 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Optimal Timing for Fetal Doppler Ultrasound in High-Risk Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Uterine Artery PI Above 95th Centile at 20 Weeks of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Routine doppler ultrasound in pregnancy.

The Cochrane database of systematic reviews, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.